Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

HIV Replicates in Brain Earlier than Thought: Study

March 26, 2015 | by Stephanie Guzowski, Editor | News | Comments

A recent study, funded by the National Institutes of Health (NIH), highlights the importance of HIV screening and beginning antiretroviral therapy (ART) as early as possible. The analysis of cerebral spinal fluid (CSF), which illuminates brain chemical activity, showed that HIV can begin replicating in a patient’s brain as early as four months after infection. Read more...

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Novo Nordisk Resubmits NDA for Tresiba, Ryzodeg in U.S.

March 26, 2015 4:38 pm | News | Comments

The resubmission is expected to take place within the next month. Read more...

TOPICS:

Takeda's NDA for Type 2 Diabetes Drug Gets Japanese Approval

March 26, 2015 4:26 pm | News | Comments

Zafatek is a once-weekly DPP-4 inhibitor. Read more...

TOPICS:

Cane Toads Potentially Lucrative Export in Cancer Fight

March 26, 2015 4:12 pm | by University of Queensland | News | Comments

Scientists are exploring how cane toad venom can be used to fight cancer. Read more...

TOPICS:
Advertisement

Multistate Investigation Announced into Premera Cyberattack

March 26, 2015 2:10 pm | by Derrick Nunnally, Associated Press | News | Comments

Washington state's insurance commissioner announced a multistate investigation into this winter's cyberattack on Premera Blue Cross. Read more...

TOPICS:

Stemedica: Worldwide License for Stem Cell Stabilization Technologies

March 26, 2015 1:41 pm | News | Comments

Stemedica Cell Technologies Inc., (Stemedica), announced that Universal Stabilization Technologies (UST) has granted to Stemedica subsidiary StemProtein, LLC, an exclusive worldwide license to its technology known as Preservation by Vaporization (PBV). Read more...

TOPICS:

Germany's Pharmaceutical Market Value will Crawl to $65 Billion by 2020

March 26, 2015 11:38 am | by Joshua Owide, Director of Healthcare Industry Dynamics, GlobalData | Articles | Comments

Germany is a mature market with high healthcare expenditure and pharmaceutical production. Read more...

TOPICS:

Men’s Heart Disease Partly Due to Low Estrogen

March 26, 2015 8:52 am | by Cynthia Fox, Science Writer | Articles | Comments

One reason men have more heart disease than women is the very fact that they are men, reports Harvard University endocrinologist Evelyn Yu, M.D., MS.c. Both men’s higher testosterone levels and their lower estrogen levels, play a role. Read more...

TOPICS:

Ebola More Deadly for Young Children

March 26, 2015 8:37 am | by Sam Wong, Imperial College London | News | Comments

An international group of scientists analyzed data on Ebola cases in children under 16 during the current outbreak in Guinea, Liberia and Sierra Leone, comparing them to cases in adults. Read more...

TOPICS:
Advertisement

GSK Gains Japanese Approval for COPD Therapy

March 26, 2015 8:25 am | News | Comments

Following this approval, it is expected that launch will take place in Japan in 2015. Read more...

TOPICS:

Ugandan Official: Typhoid Sickens Hundreds in Capital

March 25, 2015 2:15 pm | by Rooney Muhumuza, Associated Press | News | Comments

An outbreak of typhoid fever has infected hundreds of people in the Ugandan capital, Kampala, and looks likely to spread as the rainy season gets under way. Read more...

TOPICS:

Study Announces Durable Ebola Vaccine

March 25, 2015 2:10 pm | by Andrew Gould, University of Plymouth | News | Comments

A new study shows the durability of a novel CMV-based Ebola virus vaccine strategy that may eventually have the potential to reduce ebola virus infection in wild African ape species. Read more...

TOPICS:

A Look at Some Key Statistics on Rare Diseases in the U.S.

March 25, 2015 1:45 pm | by The Associated Press | News | Comments

The global pharmaceutical industry is make huge investments in treatments for rare diseases, which once drew little interest from major drugmakers. Read more...

TOPICS:

FDA Approves Anthrax Treatment

March 25, 2015 1:10 pm | by Stephanie Guzowski, Editor | News | Comments

The Food and Drug Administration (FDA) yesterday approved Emergent BioSolutions’ infusible drug Anthrasil for use in combination with antibiotics to treat inhalational anthrax, which happens when bacterial spores that carry anthrax are breathed in. Read more...

TOPICS:

Sepsis-Specific Treatment Market Will Expand from 2016, Reach $354M by 2021

March 25, 2015 12:28 pm | by Marc C. Hansel, Ph.D., GlobalData Infectious Diseases Analyst | Articles | Comments

GlobalData's latest report states that this growth will be driven by the increased uptake of novel therapies. Read more...

TOPICS:

Science, Patients Driving Rare Disease Drug Research Surge

March 25, 2015 11:34 am | by Linda A. Johnson, AP Business Writer | News | Comments

The global pharmaceutical industry is pouring billions of dollars into developing treatments for rare diseases, which once drew little interest from major drugmakers but now point the way toward a new era of innovative therapies and big profits. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading